3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years

Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL), and Regeneron Pharmaceuticals (NASDAQ: REGN). Here's a look at how much a $1,000 investment into each of these stocks back then would be worth now, and whether it's still a good idea to invest in them.

Booking Holdings: $180,000

Over the past two decades, Booking Holdings has experienced significant growth as demand for its online booking services has skyrocketed. Back in 2004, the company generated more than $914 million in sales, posting profits of $31.5 million. The business was profitable and the long-term potential was alluring, with massive opportunities opening up due to more widespread use of the internet.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

Today, the business is worth around $150 billion, and it would have a turned a $1,000 investment into approximately $180,000 over 20 years. Last year, it reported $23.7 billion in sales, and its profits totaled $5.9 billion. Booking.com, Kayak.com, and Priceline.com are some of the names travelers first go to when looking to book a trip -- and Booking Holdings owns all those brands.

As well as it has done over the past couple of decades, it still looks like a good buy and a way to bet on the travel industry's future growth. Even if the near term may be a challenging one for economies around the world, investing in Booking Holdings can still be a great move for the long haul.

Apple: $151,000

At a market cap of $3.3 trillion, Apple is the most valuable company in the world today. Even though it may not be the innovative company it was a decade or so ago, its ability to build on its flagship iPhone and create the iPad and other products and services along the way has enabled the business to become a behemoth.

Apple's growth these days is a bit modest, as revenue for the last three months of 2024 was up just 4%, but it still has opportunities in its services business to drive more growth. That segment generated 14% revenue growth last quarter, and at $26.3 billion, it now accounts for more than one-fifth of the company's total revenue.

The stock may not generate 100-fold returns for investors who buy it today, but it can still make for a dependable investment to buy, hold, and simply forget about. Apple's business looks rock-solid, and it's little wonder Warren Buffett says it's the "best business" he knows of -- on top of having an iconic consumer brand, it has generated more than $98 billion in free cash flow over the trailing 12 months.

Regeneron Pharmaceuticals: $125,000

Rounding out this list is healthcare company Regeneron Pharmaceuticals. A couple of decades ago, this would have been a fairly risky stock to own. While it did post a profit in 2004, that was because it experienced a significant boost in contract research and development revenue. But in the two previous years, its net losses totaled more than $100 million.

The business is much safer today: It generated more than $14.2 billion in sales for 2024, with net income coming in at over $4.4 billion. Its medication for wet age-related macular degeneration, Eylea, wasn't approved until 2011; last year it brought in $6 billion in revenue.

Regeneron has more growth opportunities ahead, as it has a strong pipeline which features dozens of possible drug candidates. This pharma stock can be a good one to buy and hold on to, and it's cheap too, trading at just 14 times its estimated future earnings.

Should you invest $1,000 in Apple right now?

Before you buy stock in Apple, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Apple wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $623,941!*

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 1, 2025

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple, Booking Holdings, and Regeneron Pharmaceuticals. The Motley Fool has a disclosure policy.